|
|
ICON plc - Comparative Business Analysis Snapshot
Business Description
ICON plc. The Group's principal activity is providing clinical research and development services on a global basis to the pharmaceutical, biotechnology and medical device industries. It specializes in the development, management and analysis of programs that support Clinical Development - from compound selection to Phase I-IV clinical studies. The Group operates offices in 71 locations in 38 countries worldwide. During the 2008 the Group acquired 100% of Healthcare Discoveries Inc. and Prevalere Life Sciences Inc.
Competitor Analysis
This analysis compares ICON plc with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
